Long-term changes in renal function and perfusion in heart failure patients with reduced ejection fraction

Clinical Research in Cardiology

Volumn 105, Issue 1, 2016, Pages 10-16

  Schroten, Nicolas F ^a   Damman, Kevin ^a   Valente, Mattia A E ^a   Smilde, Tom D ^b   van Veldhuisen, Dirk J ^a   Navis, Gerjan ^a   Gaillard, Carlo A ^a   Voors, Adriaan A ^a   Hillege, Hans L ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b Scheper Ziekenhuis   (Netherlands)

Author keywords

Biomarkers; Cardiorenal; Heart failure; Kidney; Renal blood flow

Indexed keywords

ALDOSTERONE ANTAGONIST; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; IODINE 125; IODOHIPPURATE SODIUM I 131; IOTALAMIC ACID I 125; KIDNEY INJURY MOLECULE 1; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; IODOHIPPURIC ACID; IOTALAMIC ACID;

ADULT; AGE; ARTICLE; FEMALE; GLOMERULUS FILTRATION RATE; HEART EJECTION FRACTION; HEART FAILURE; HEART VENTRICULOGRAPHY; HUMAN; KIDNEY FUNCTION; KIDNEY PERFUSION; KIDNEY PLASMA FLOW; KIDNEY VASCULAR RESISTANCE; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; PROSPECTIVE STUDY; URINALYSIS; AGED; COMPLICATION; FOLLOW UP; HEART LEFT VENTRICLE FUNCTION; HEMODYNAMICS; KIDNEY DISEASES; KIDNEY FUNCTION TEST; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; RISK FACTOR;

AGE FACTORS; AGED; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HEART FAILURE; HEMODYNAMICS; HUMANS; IODOHIPPURIC ACID; IOTHALAMIC ACID; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; RISK FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84955205388     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-015-0881-9     Document Type: Article

References (26)

1. Cruz DN, Gheorghiade M, Palazzuoli A, Ronco C, Bagshaw SM (2011) Epidemiology and outcome of the cardio-renal syndrome. Heart Fail Rev 16:531–542
2. Ohlmeier C, Mikolajczyk R, Frick J, Prutz F, Haverkamp W, Garbe E (2015) Incidence, prevalence and 1-year all-cause mortality of heart failure in Germany: a study based on electronic healthcare data of more than six million persons. Clin Res Cardiol
3. Franke J, Zugck C, Wolter JS, Frankenstein L, Hochadel M, Ehlermann P, Winkler R, Nelles M, Zahn R, Katus HA, Senges J (2012) A decade of developments in chronic heart failure treatment: a comparison of therapy and outcome in a secondary and tertiary hospital setting. Clin Res Cardiol 101:1–10
4. Damman K, Valente MA, Voors AA, O’Connor CM, van Veldhuisen DJ, Hillege HL (2014) Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis. Eur Heart J 35:455–469
5. Bongartz LG, Cramer MJ, Doevendans PA, Joles JA, Braam B (2005) The severe cardiorenal syndrome: ‘Guyton revisited’. Eur Heart J 26:11–17
6. Damman K, Kalra PR, Hillege H (2010) Pathophysiological mechanisms contributing to renal dysfunction in chronic heart failure. J Ren Care 36(Suppl 1):18–26
7. Knight EL, Glynn RJ, McIntyre KM, Mogun H, Avorn J (1999) Predictors of decreased renal function in patients with heart failure during angiotensin-converting enzyme inhibitor therapy: results from the studies of left ventricular dysfunction (SOLVD). Am Heart J 138:849–855
8. Schroten NF, Gaillard CA, van Veldhuisen DJ, Szymanski MK, Hillege HL, de Boer RA (2012) New roles for renin and prorenin in heart failure and cardiorenal crosstalk. Heart Fail Rev 17:191–201
9. Smilde TD, Damman K, van der Harst P, Navis G, Westenbrink BD, Voors AA, Boomsma F, van Veldhuisen DJ, Hillege HL (2009) Differential associations between renal function and “modifiable” risk factors in patients with chronic heart failure. Clin Res Cardiol 98:121–129
10. Damman K, Navis G, Smilde TD, Voors AA, van der Bij W, van Veldhuisen DJ, Hillege HL (2007) Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction. Eur J Heart Fail 9:872–878
11. de Silva R, Nikitin NP, Witte KK, Rigby AS, Goode K, Bhandari S, Clark AL, Cleland JG (2006) Incidence of renal dysfunction over 6 months in patients with chronic heart failure due to left ventricular systolic dysfunction: contributing factors and relationship to prognosis. Eur Heart J 27:569–581
12. MacDowall P, Kalra PA, O’Donoghue DJ, Waldek S, Mamtora H, Brown K (1998) Risk of morbidity from renovascular disease in elderly patients with congestive cardiac failure. Lancet 352:13–16
13. Forman DE, Butler J, Wang Y, Abraham WT, O’Connor CM, Gottlieb SS, Loh E, Massie BM, Rich MW, Stevenson LW, Young JB, Krumholz HM (2004) Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol 43:61–67
14. Krumholz HM, Chen YT, Vaccarino V, Wang Y, Radford MJ, Bradford WD, Horwitz RI (2000) Correlates and impact on outcomes of worsening renal function in patients > or = 65 years of age with heart failure. Am J Cardiol 85:1110–1113
15. Tent H, Waanders F, Krikken JA, Heerspink HJ, Stevens LA, Laverman GD, Navis G (2012) Performance of MDRD study and CKD-EPI equations for long-term follow-up of nondiabetic patients with chronic kidney disease. Nephrol Dial Transplant 27(Suppl 3):iii89–95
16. Donker AJ, van der Hem GK, Sluiter WJ, Beekhuis H (1977) A radioisotope method for simultaneous determination of the glomerular filtration rate and the effective renal plasma flow. Neth J Med 20:97–103
17. Apperloo AJ, de Zeeuw D, Donker AJ, de Jong PE (1996) Precision of glomerular filtration rate determinations for long-term slope calculations is improved by simultaneous infusion of 125I-iothalamate and 131I-hippuran. J Am Soc Nephrol 7:567–572
18. Damman K, Van Veldhuisen DJ, Navis G, Vaidya VS, Smilde TD, Westenbrink BD, Bonventre JV, Voors AA, Hillege HL (2010) Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate. Heart 96:1297–1302
19. Weinstein JR, Anderson S (2010) The aging kidney: physiological changes. Adv Chronic Kidney Dis 17:302–307
20. Damman K, van Veldhuisen DJ, Navis G, Voors AA, Hillege HL (2008) Urinary neutrophil gelatinase associated lipocalin (NGAL), a marker of tubular damage, is increased in patients with chronic heart failure. Eur J Heart Fail 10:997–1000
21. Pfister R, Muller-Ehmsen J, Hagemeister J, Hellmich M, Erdmann E, Schneider CA (2011) NT-pro-BNP predicts worsening renal function in patients with chronic systolic heart failure. Intern Med J 41:467–472
22. Aghel A, Shrestha K, Mullens W, Borowski A, Tang WH (2010) Serum neutrophil gelatinase-associated lipocalin (NGAL) in predicting worsening renal function in acute decompensated heart failure. J Card Fail 16:49–54
23. Macdonald S, Arendts G, Nagree Y, Xu XF (2012) Neutrophil Gelatinase-Associated Lipocalin (NGAL) predicts renal injury in acute decompensated cardiac failure: a prospective observational study. BMC Cardiovasc Disord 12:8-2261-12-8
24. Damman K, Masson S, Hillege HL, Voors AA, van Veldhuisen DJ, Rossignol P, Proietti G, Barbuzzi S, Nicolosi GL, Tavazzi L, Maggioni AP, Latini R (2013) Tubular damage and worsening renal function in chronic heart failure. JACC Heart Fail 1:417–424
25. Palmer BF (2002) Renal dysfunction complicating the treatment of hypertension. N Engl J Med 347:1256–1261
26. Leistner DM, Klotsche J, Pieper L, Palm S, Stalla GK, Lehnert H, Silber S, Marz W, Wittchen HU, Zeiher AM (2013) Prognostic value of NT-pro-BNP and hs-CRP for risk stratification in primary care: results from the population-based DETECT study. Clin Res Cardiol 102:259–268